Praxis Precision Medicines shares traded on the Nasdaq exchange, while RBC Capital reaffirmed Buy rating and HC Wainwright maintained Buy rating and revised EPS forecasts.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Praxis Precision Medicines shares traded on the Nasdaq exchange, while RBC Capital reaffirmed Buy rating and HC Wainwright maintained Buy rating and revised EPS forecasts.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
RBC Capital Markets
global investment bank
- Financial institutions like RBC and Macquarie maintained 'outperform' ratings amid dashed hopes for a Strait of Hormuz reopening.
- Kratos Defense & Security Solutions filed a shelf registration statement with the SEC, with Robert W. Baird & Co. and RBC Capital Markets acting as joint book-running managers.
Related events
- Trades are occurring on the Nasdaq stock exchange involving MarketAxess as of August 17, 2026.
- ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
- FirstCash traded on the Nasdaq stock exchange, filed required reports with the SEC, and saw its stock price affected by analyst ratings.
- Iridex Corporation is trading on the Nasdaq stock exchange.
- Penguin Solutions, Inc. stock traded on Nasdaq, with Citigroup providing rating updates and legal filings made with the SEC.